Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income including noncontrolling interests	$ 407,368	$ 387,528
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	75,568	64,034
Impairment and related charges	0	4,486
Share-based compensation expense related to equity classified awards	50,465	52,006
Non-cash restructuring and other related charges	14,026	0
Amortization and write-off of program rights	696,326	684,289
Amortization of deferred carriage fees	14,624	13,107
Unrealized foreign currency transaction loss (gain)	489	(712)
Unrealized gain on derivative contracts, net	0	(40,848)
Amortization of deferred financing costs and discounts on indebtedness	5,970	5,746
Bad debt expense	3,628	6,155
Deferred income taxes	(65,245)	39,404
Write-down of non-marketable equity securities and note receivable	20,206	0
Other, net	(8,481)	(887)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	6,993	(2,333)
Prepaid expenses and other assets	(121,375)	(27,769)
Program rights and obligations, net	(676,718)	(671,108)
Income taxes payable	3,101	(5,005)
Deferred revenue	10,395	3,531
Deferred carriage fees, net	(14,409)	(3,200)
Accounts payable, accrued liabilities and other liabilities	(22,534)	(36,612)
Net cash provided by operating activities	400,397	471,812
Cash flows from investing activities:
Capital expenditures	(69,096)	(60,774)
Return of capital from investees	9,232	523
Investment in and loans to investees	0	(90,080)
Payments for acquisition of a business, net of cash acquired	0	(35,554)
Net cash used in investing activities	(59,864)	(185,885)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	1,521	0
Principal payments on long-term debt	(12,613)	0
Deemed repurchases of restricted stock units	(23,019)	(15,734)
Purchase of treasury stock	(70,598)	(267,400)
Proceeds from stock option exercises	4,630	4,317
Principal payments on finance lease obligations	(4,059)	(3,878)
Distributions to noncontrolling interests	(13,545)	(9,333)
Net cash used in financing activities	(117,683)	(292,028)
Net increase (decrease) in cash and cash equivalents from operations	222,850	(6,101)
Effect of exchange rate changes on cash and cash equivalents	(4,350)	12,035
Cash and cash equivalents at beginning of period	554,886	558,783
Cash and cash equivalents at end of period	$ 773,386	$ 564,717